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AdriamycinForegut division—the separation of dorsal (oesophageal) from ventral (tracheal) foregut components—is a
crucial event in gastro-respiratory development, and frequently disturbed in clinical birth defects. Here, we
examined three outstanding questions of foregut morphogenesis. The origin of the trachea is suggested to
result either from respiratory outgrowth or progressive septation of the foregut tube. We found normal
foregut lengthening despite failure of tracheo-oesophageal separation in Adriamycin-treated embryos,
whereas active septation was observed only in normal foregut morphogenesis, indicating a primary role for
septation. Dorso-ventral patterning of Nkx2.1 (ventral) and Sox2 (dorsal) expression is proposed to be
critical for tracheo-oesophageal separation. However, normal dorso-ventral patterning of Nkx2.1 and Sox2
expression occurred in Adriamycin-treated embryos with defective foregut separation. In contrast, Shh
expression shifts dynamically, ventral-to-dorsal, solely during normal morphogenesis, particularly implicat-
ing Shh in foregut morphogenesis. Dying cells localise to the fusing foregut epithelial ridges, with
disturbance of this apoptotic pattern in Adriamycin, Shh and Nkx2.1 models. Strikingly, however, genetic
suppression of apoptosis in the Apaf1 mutant did not prevent foregut separation, indicating that apoptosis is
not required for tracheo-oesophageal morphogenesis. Epithelial remodelling during septation may cause loss
of cell-cell or cell-matrix interactions, resulting in apoptosis (anoikis) as a secondary consequence.
© 2009 Elsevier Inc. Open access under CC BY license.Introduction
Oesophageal atresia (OA) and tracheo-oesophageal ﬁstula (TOF)
are common foregut malformations, affecting around 1 in 3500 births
and frequently requiring emergency surgery in the neonatal period
(Shaw-Smith, 2006). While advances have been made in understand-
ing the genetic aetiology of syndromic forms of OA/TOF (Garcia-
Barcelo et al., 2008; Van Bokhoven et al., 2005; Vissers et al., 2004;
Williamson et al., 2006), the majority of cases are non-syndromic and
their cause is unknown (Ioannides and Copp, 2009). Moreover, the
mechanisms underlying the embryonic and fetal development of OA/
TOF are poorly understood.
The oesophagus and trachea develop from a single embryonic
structure: the anterior foregut tube. The respiratory primordium
appears during development when the laryngo-tracheal grooveth, 30 Guilford Street, London
netics, Guy's Hospital, London,
 license.emerges from the ventral aspect of the post-pharyngeal foregut.
Caudal elongation of the laryngo-tracheal groove along the undivided
foregut generates the laryngeal and tracheal primordia. Bifurcation
and subsequent branching of the posterior-most aspect of the res-
piratory primordium gives rise to the bronchi and lungs. Shortly after
appearance of the broncho-pulmonary bifurcation, the dorsal, oeso-
phageal part of the foregut tube begins to separate from the ventral,
tracheal component, with a wave of morphogenesis travelling in a
caudal-to-cranial direction along the foregut. Separation occurs in
the human embryo between Carnegie stages 13 and 16 (28–37 days
post-fertilisation), and between embryonic days (E) 11 and 12 in the
mouse.
While the early events of tracheo-oesophageal separation are
difﬁcult to study in human embryos and fetuses, information has
emerged from a teratogenic model of OA/TOF based on exposure of
mid-gestation rat embryos to Adriamycin (doxorubicin). This anthra-
cycline antibiotic enters the nucleus and intercalates into DNA,
interfering with DNA replication and transcription (Diez-Pardo et al.,
1996). We adapted the Adriamycin teratogenic model for use in the
mouse, in order to facilitate molecular and genetic studies (Ioannides
et al., 2002, 2003). Partial or complete failure of separation of the
352 A.S. Ioannides et al. / Developmental Biology 337 (2010) 351–362respiratory and gastrointestinal foregut components was observed in
47% of Adriamycin-treated mouse embryos and fetuses. In the present
study we compared the embryonic pathogenesis of OA/TOF in
Adriamycin-treated mice, and in mice lacking function of sonic
hedgehog (Shh) or Nkx2.1. Shh null embryos exhibit severe tracheo-
oesophageal malformations (Litingtung et al., 1998; Pepicelli et al.,
1998), as do mice with mutations in genes downstream from Shh,
namely Gli2−/−; Gli3+/− double mutants (Motoyama et al., 1998)
and Foxf1 heterozygotes (Mahlapuu et al., 2001). In addition, mice
null for Nkx2.1 also develop OA/TOF, with a phenotype closely
resembling the human malformation (Minoo et al., 1999).
The present study addresses three distinct questions relating to
the morphogenetic mechanisms that underlie foregut separation,
and which are disrupted in OA/TOF. First, we studied the growth
dynamics of the developing foregut in order to distinguish between
two alternative models of early tracheal morphogenesis. According to
the ‘septation’ model, foregut division occurs when paired epithelio-
mesenchymal ridges, arising from the lateral aspects of the foregut
tube, fuse to form a septum. This separates the foregut lumen into
dorsal (gastrointestinal) and ventral (respiratory) components (Qi
and Beasley, 2000). Although often considered the most likely
mechanism for tracheo-oesophageal separation, direct evidence of
septum formation has been lacking (Kluth et al., 1987; O'Rahilly and
Muller, 1984; Sasaki et al., 2001; Zaw-Tun, 1982). An alternative
‘tracheal outgrowth’ hypothesis considers the trachea to develop as a
result of rapid growth of the respiratory primordium away from the
foregut tube (Sasaki et al., 2001; Zaw-Tun, 1982). This model does not
require the existence of lateral ridges or a septum, and is in keeping
with the development of other foregut derivatives. For example, the
thyroid, thymus and parathyroid glands bud off the foregut and grow
rapidly away from it, eventually losing their original foregut
connections.
The second aim of the present study was to determine whether
loss of dorso-ventral gene expression patterning in the foregut tube is
a pre-requisite for failure of tracheo-oesophageal separation. Nkx2.1
and Sox2 are expressed speciﬁcally in ventral and dorsal foregut
endoderm, respectively, with a common dorso-ventral boundary
separating the expression domains (Minoo et al., 1999; Que et al.,
2007). In mice lacking Sox2 function, OA/TOF coincides with ectopic
(dorsal) expression of Nkx2.1 in the foregut. Conversely, Sox2 is
ectopically expressed in OA/TOF resulting fromNkx2.1 loss of function
(Minoo et al., 1999; Que et al., 2007). It has been suggested, therefore,
that disturbance of foregut dorso-ventral patterningmay be a primary
mechanism leading to failure of tracheo-oesophageal separation. We
examined this idea further by determining whether dorso-ventral
patterning is disrupted in the Adriamycin and Shh-null mouse models
of OA/TOF.
The third focus of this paper relates to a possible requirement for
programmed cell death (PCD) in foregut division. Several studies have
identiﬁed dying cells in the region of tracheo-oesophageal separation,
and have noted reduced apoptosis in Adriamycin-treated rat embryos
(Orford et al., 2001; Qi and Beasley, 1998, 2000; Williams et al., 2000;
Zhou et al., 1999). It has not been determined, however, whether this
apoptosis is necessary for successful foregut separation or, alterna-
tively, may be a secondary phenomenon. Here, we used a genetic
approach to suppress embryonic apoptosis in order to determine the
functional role of PCD in foregut separation.
Materials and methods
Mouse strains and Adriamycin administration
Inbred CBA/Ca mice (Harlan, UK) were used as the ‘normal’ strain
in this study. Adriamycin (Pharmacia & Upjohn UK) was administered
to pregnant females at 4 mg/kg body weight on both E7.5 and E8.5
(Ioannides et al., 2002). Salinewas administered as a control. Embryoshomozygous for a Shh null mutation were generated by matings
between heterozygotes, as described (Chiang et al., 1996). Apaf1 and
Nkx2.1 wild-type and null embryos were bred and genotyped as
described (Cecconi et al., 1998; Tekki-Kessaris et al., 2001).
Histology, immunohistochemistry and in situ hybridisation
Embryos were ﬁxed in 4% paraformaldehyde and parafﬁn sections
(5–10 μm thickness) were processed for Methyl Green or Periodic
Acid Schiff (PAS) staining, immunohistochemistry (Ioannides et al.,
2002) or RNA in situ hybridisation using digoxygenin-labelled ribop-
robes for Shh and Sox2 (Avilion et al., 2003) as described previously
(Breitschopf et al., 1992). Primary antibodies were: anti-Nkx2.1
(1:100, NeoMarkers MS-699-P1), anti-activated Caspase 3 (1:1000,
Cell Signaling 9661S) and anti-Phosphohistone H3 (1:200, Upstate
06-570). Secondary antibodies were: biotinylated rabbit anti-mouse
(DAKO E0354) and biotinylated goat anti-rabbit (DAKO E0432).
Respiratory foregut length analysis
The respiratory foregut was identiﬁed by immunohistochemistry
for Nkx2.1, a transcription factor speciﬁc for the respiratory system
(Minoo et al., 1999). Its rostral and caudal limits and the level of
tracheo-oesophageal separation were identiﬁed on transverse sec-
tions. The length of individual foregut segments was calculated by
counting the number of corresponding sections of known thickness.
Cell proliferation and programmed cell death (PCD) analysis
Data for calculation of mitotic and PCD indices were collected from
sections at different rostro-caudal levels and individual dorso-ventral
foregut zones. At E10.5, levels 1 and 4were deﬁned respectively as the
rostro-caudal positions of the laryngotracheal groove and emerging
lung buds, while levels 2 and 3 were evenly spaced between these
levels. At E11.5, levels 1, 3, 6 and 7 were deﬁned as the rostro-caudal
positions of the laryngotracheal groove, point of tracheo-oesophageal
separation, tracheal bifurcation, and separated bronchi and oeso-
phagus. Levels 2, 4, and 5 were evenly interpolated between these
levels. The spatial pattern of PCD was further analysed using a
templating technique (Sharma et al., 2004) in which apoptotic cells
from sections of corresponding rostro-caudal levels from different
embryos are superimposed onto a single template section. This
method can reveal spatial patterns of cell death that may not be
obvious from observation of small numbers of apoptotic cells in
individual sections.
Graphical and statistical analysis
Quantitative data were represented by vertical box plots prepared
using Sigmaplot (version 4.01). Vertical boxes with error bars deﬁne
the median, 10th, 25th, 75th and 90th percentile values and all
outlying values are represented by dots. Statistical comparisons
(Sigmastat, version 1.0) were performed using the unpaired t-test
(where data were normal) or the Mann–Whitney test (if normality
failed). A p-value smaller than 0.05 was considered signiﬁcant.
Results
In the mouse, 40% of Adriamycin-treated embryos exhibit failure
of foregut division, giving rise to a malformation closely resembling
human OA/TOF. In normal E15.5 embryos, the trachea and oeso-
phagus are present as distinct structures (Figs. 1A, C), whereas
Adriamycin-treated embryos have an undivided oesophagotrachea
(Figs. 1B, D). At E18.5, whole mount preparations demonstrate not
only the lack of tracheo-oesophageal separation, but also the trifur-
cation at the level of the lung buds in Adriamycin-treated embryos,
Fig. 1. Structure of the foregut in normal and Adriamycin-treated mouse fetuses. (A–D)
Sagittal (A, B) and transverse (C, D) sections stained with haematoxylin & eosin through
E15.5 saline-treated (A, C) and Adriamycin-treated (B,D) fetuses. The level of the
transverse sections in C and D corresponds to the level of the dashed lines in A and B
(level of clavicular heads (Cl) and thoracic inlet). (E,F) Dissected anterior foregut
structures from E18.5 saline-treated (E) and Adriamycin-treated (F) fetuses. After
saline treatment (A, C, E), the oesophagus (Oe) and trachea (Tr) are separate structures
in contrast to Adriamycin-treated fetuses (B, D, F) which have an undivided oeso-
phagotrachea (Oet) at the same level. The ﬁstula (Fi) arises from the oesophagotrachea
at the level of the cardiac outﬂow tract (white arrow in B), forming a trifurcation with
the main bronchi (white arrow in F), and connecting to a small, globular stomach (St).
Note the prominent cartilaginous rings in the saline-treated trachea (E), whereas these
appear completely absent from the Adriamycin-treated oesophagotrachea (F).
Abbreviations: Br, bronchus; H, heart; Lu, lungs; Sal, salivary glands; Th, thyroid
gland. Scale bars, 200 μm.
Fig. 2. Respiratory foregut length analysis. Box plots showing total respiratory foregut
length (A) and corresponding lengths of divided and undivided segments (B) according
to gestational age. (A) Unaffected (normal phenotype) and affected (abnormal
phenotype) Adriamycin-treated embryos are indistinguishable morphologically at
E10.5, and their lengths are grouped together (red box). Note the closely similar overall
foregut growth trajectories in all groups. (B) Lengths of undivided (yellow boxes) and
divided (green boxes) foregut are shown for saline-treated controls (upper graph) and
affected Adriamycin-treated embryos (lower graph). Unaffected Adriamycin-treated
embryos have been omitted for clarity. Note the progressive division of the foregut in
controls, but persistence of undivided foregut in affected Adriamycin-treated embryos.
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stomach (Fig. 1F). In normal embryos, the oesophageal connection to
the stomach is entirely separate from the tracheal connection to the
lungs (Fig. 1E). There is a striking lack of cartilage development in the
oesophagotrachea (Fig. 1F) compared with the normally separated
trachea (Fig. 1E).
Foregut growth during normal and abnormal tracheo-oesophageal
separation
To investigate the mode of origin of the trachea, as a structure
distinct from the oesophagus, we measured the length of the
respiratory component of the foregut, and of its divided and
undivided segments, between E10.5 and E12.5. The respiratory
foregut, between the subglottic larynx and the tracheal bifurcation,
was identiﬁed by immunohistochemistry for Nkx2.1 (also called TTF-
1 and T/EBP), a transcription factor speciﬁc for the respiratory system
(Minoo et al., 1999).The foregut is entirely undivided in normal E10.5 CBA/Ca embryos,
whereas tracheo-oesophageal separation is underway at E11.5, and
the trachea and oesophagus are largely separate structures by E12.5.
While this morphogenetic activity is occurring, the respiratory foregut
increases in length linearly (Fig. 2A, blue boxes). Strikingly, although
the total length of the respiratory foregut increases signiﬁcantly from
E10.5 to E11.5 (Fig. 2A; pb0.0001), the length of the undivided
segment is signiﬁcantly shorter at E11.5 than at E10.5 (yellow boxes
in Fig. 2B, upper graph; pb0.0001). At E12.5, the separation process is
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remains undivided (Fig. 2B upper graph). Hence, the further signi-
ﬁcant increase in total length of the respiratory foregut between E11.5
and E12.5 (Fig. 2A; pb0.0001) is contributed to almost exclusively by
growth of the separated trachea.
Following Adriamycin treatment, all embryos have an undivided
foregut at E10.5, as in untreated CBA/Ca controls (Fig. 2A, red box). At
E11.5 and E12.5, approximately 60% of Adriamycin-treated embryos
also resemble controls, showing a partially (E11.5) or completely
(E12.5) divided foregut. These unaffected embryos show a linear
increase in total foregut length between E10.5 and E12.5 (Fig. 2A, pink
boxes), with a lengthening of the divided segment and a shortening of
the undivided segment in a manner closely similar to untreated
controls (data not shown). In contrast, 40% of Adriamycin-treated
embryos (n=13/45 at E11.5; 12/20 at E12.5) have either a totally
undivided foregut or only a very short divided segment. In these
affected embryos, the divided segment remains signiﬁcantly shorter
than in control embryos at both E11.5 and E12.5, whereas the
undivided segment is signiﬁcantly longer (Fig. 2B lower graph;
pb0.0001). Nevertheless, the total foregut length increases linearly to
the same extent in these embryos as in unaffected Adriamycin-treated
and untreated control embryos (Fig. 2A, brown boxes).
In conclusion, while total respiratory foregut length increases
linearly from E10.5 to E12.5, this is independent of tracheo-
oesophageal separation: similar growth dynamics are observed in
both affected Adriamycin-treated embryos and untreated controls.
Moreover, the absolute length of undivided foregut decreases as
the length of divided foregut increases in normal embryos. These
ﬁndings strongly suggest a process of tracheo-oesophageal separa-
tion, progressively along the length of the foregut, but not a model
based on speciﬁc outgrowth and lengthening of the respiratory
primordium.
Dorso-ventral gene expression patterning during tracheo-oesophageal
separation
Previously, we described a ventral-to-dorsal shift in expression of
Shh, just rostral to the wave of separation as it passes up the normal
foregut (Ioannides et al., 2003). At E10.5, the ventral ‘tracheal’ foregut
domain is positive for Shh, while the dorsal ‘oesophageal’ domain is
negative. However, by E11.5, the expression pattern is reversed so
that the dorsal domain is now Shh-positive, while the ventral domain
is Shh-negative. Importantly, Adriamycin-treated embryos with faulty
tracheo-oesophageal separation fail to exhibit this ventral-dorsal
shift: the undivided foregut exhibits relatively uniform Shh expression
along the dorso-ventral axis, at both E10.5 and E11.5, and lacks a clear
dorso-ventral expression boundary (Ioannides et al., 2003). To
determine whether disturbance of dorso-ventral patterning is an
obligatory feature of OA/TOF, we performed immunohistochemistry
for the ventrally restricted foregut marker Nkx2.1 (Minoo et al., 1999)
and in situ hybridisation for the dorsal marker Sox2 (Que et al., 2007)
in both normal and Adriamycin-treated embryos.
Normal development
We conﬁrmed that Nkx2.1 protein is restricted to the ventral,
future respiratory foregut of both E10.5 and E11.5 embryos, at all
rostro-caudal levels including the laryngotracheal groove (Figs. 3A,
G), the undivided foregut (Figs. 3B, H) and the lung buds (Figs. 3E, R).
Periodic Acid Schiff (PAS), a marker of mucopolysaccharide-richFig. 3. Dorso-ventral patterning in the foregut during tracheo-oesophageal separation. (A–
show in situ hybridisation for Sox2, and (T) which is stained with respiratory-speciﬁc Perio
E12.5 (T–Z), at levels indicated by the schematic representations. Red dotted lines on schem
oesophagus, arrowhead in (S) points to ﬁstula, and all other arrowheads indicate dorso-ven
bud; Lt, laryngotracheal groove; Oe, oesophagus; Oet, oesophagotrachea; Th, thyroid; Tr, trrespiratory epithelium (ten Have-Opbroek et al., 1991), demonstrates
that Nkx2.1 expression coincides with the pattern of respiratory
cell differentiation in the foregut endoderm (Figs. 3O, P). At E12.5,
when tracheo-oesophageal separation is almost complete, the ventral
foregut including infraglottic larynx (Fig. 3T) and trachea (Figs. 3W, Y)
remain strongly positive for Nkx2.1, whereas the oesophagus is
negative (Figs. 3W, Y). In contrast, Sox2 transcripts are dorsally lo-
cated in the normal foregut, both prior to and following tracheo-
oesophageal separation, with a sharp expression boundary between
dorsally positive and ventrally negative domains (Figs. 3K, L). This
boundary appears to be closely similar to that respected by Nkx2.1
(compare Figs. 3H and K).
Adriamycin-induced OA/TOF
Adriamycin-treated embryos are comparable in stage to untreated
control embryos as judged by somite number at E10.5 and E11.5
(Supplementary Fig. 1A). Moreover, early developmental events
(E10.5) within the anterior foregut are not overtly disturbed by
Adriamycin treatment, as judged by morphology and Nkx2.1 ex-
pression at rostral (compare Figs. 3A, C), intermediate (Figs. 3B, D)
and caudal (Figs. 3E, F) levels. Tracheo-oesophageal development
ﬁrst diverges from normal at E11.5 when around 40% of Adriamycin-
treated embryos fail to initiate foregut separation (compare Figs. 3O, Q).
In these affected embryos, the undivided oesophago-trachea gives rise
to an Nkx2.1-negative foregut connection (ﬁstula) to the stomach (Fig.
3S). Despite this abnormality of foregut morphogenesis, Nkx2.1
continues to mark the respiratory elements of the Adriamycin-treated
foregut in an appropriate dorso-ventral manner. Hence, the endoderm
of the laryngotracheal groove expresses Nkx2.1 at E11.5 (Fig. 3I) and
E12.5 (Fig. 3U), and the ventral, respiratory part of the undivided
foregut remains Nkx2.1 positive, separated by a sharp boundary from
the dorsal Nkx2.1-negative oesophageal domain at E11.5 (Fig. 3Q)
and E12.5 (Figs. 3X, Z). The lung buds remain strongly Nkx2.1-positive
(Fig. 3S).
The dorsal restriction of Sox2 expression is also maintained in the
foregut of affected E11.5 Adriamycin-treated embryos, both at the
level where normal embryos have an undivided foregut (Fig. 3M)
and more caudally where normal tracheo-oesophageal separation
is complete but Adriamycin-treated embryos exhibit an undivided
oesophago-trachea (Fig. 3N). At both rostro-caudal levels, the bound-
ary between dorsally positive and ventrally negative Sox2 domains
appears closely similar to that demarcating dorsally negative and
ventrally positive Nkx2.1 domains (compare Fig. 3J with M, N).
In conclusion, both Nkx2.1 and Sox2 exhibit apparently normal
dorso-ventral patterning of gene expression in the undivided
Adriamycin-treated foregut, in contrast to the dynamic ventral-dorsal
shift of Shh expression which is abolished in embryos with faulty
tracheo-oesophageal separation.
Failure of tracheo-oesophageal separation in Shh null embryos
Foregut malformations have been described in embryos with loss
of Shh function (Litingtung et al., 1998), although the developmental
basis of the defects has not been determined. We conﬁrmed that Shh
null embryos are growth retarded, and have multiple malforma-
tions affecting forebrain, heart and limbs (Supplementary Figs. 2A, B).
However, somite number, a measure of developmental stage at
E10.5 and E11.5, does not differ signiﬁcantly with genotype in Shh
litters (Supplementary Fig. 2C), validating a comparison of foregutZ) Immunohistochemistry for the respiratory marker Nkx2.1, except for (K–N) which
dic Acid Schiff. Transverse sections are from embryos at E10.5 (A–F), E11.5 (G–S) and
atics deﬁne the levels for measuring foregut lengths as in Fig. 2. Arrow in (R) points to
tral expression boundaries. Abbreviations: Br, bronchus; Fi, ﬁstula; Fo, foregut; Lb, lung
achea. Scale bar (in Z): 125 μm in A–Q; 80 μm in R,S; 100 μm in T–Z.
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ing litter mates.
At E10.5, tracheo-oesophageal separation has just started at the
level of the lung buds in wild type littermates (Fig. 4C), thus occurring
12 h earlier than in untreated CBA/Ca embryos, presumably as a result
of the difference in genetic background. In contrast, Shh−/− embryos
at this (Fig. 4F) and subsequent stages do not exhibit foregut division.
Nevertheless, Nkx2.1 expression in E10.5 Shh−/− embryos closely
resembles that of wild type littermates, with an Nkx2.1-positive
thyroid primordium (Figs. 4A, D) and a well-deﬁned boundary
between Nkx2.1 expressing and non-expressing cells (Figs. 4B, E).
At the caudal end of the undivided foregut there is a trifurcation of
two Nkx2.1-positive lung buds and an Nkx2.1-negative ﬁstula (Fig.
4F). Hence, the appearance in E10.5 Shh−/− embryos is closely similar
to that seen in affected E11.5 Adriamycin-treated embryos.
At E11.5 and E12.5, the appearance of the undivided Shh−/−
foregut diverges from that seen in the Adriamycin model. The Shh−/−
foregut narrowsmarkedly and well-deﬁned tracheal and oesophageal
domains, as judged by Nkx2.1 expression, are no longer evident
(Figs. 4H, K). Moreover, the intensity of expression of Nkx2.1 in the
undivided foregut appears weaker than in either the thyroid
primordium or lung buds (compare Figs. 4H, K with Figs. 4G, I, J, L).
Although most of the Shh−/− undivided foregut endoderm is
Nkx2.1-positive, a narrow non-expressing domain persists dorsally
(arrowheads and arrow in Fig. 4H) giving rise, at more caudal
levels, to a partially or wholly Nkx2.1-negative ﬁstula (arrowheads in
Figs. 4I, L).
Hence, at the stagewhen foregut separation is beginning in normal
embryos, both morphology and Nkx2.1 expression pattern are closely
similar in the undivided foregut of Adriamycin-treated and Shh
mutant embryos. Considering that Shh null embryos fail to divide the
foregut, and that failed separation in the Adriamycin-treated embryos
is associated with disruption of Shh expression pattern, it also seemsFig. 4. Respiratory speciﬁcation in Shh null embryos. Nkx2.1 expression detected by immunoh
(A, D, G, J) Pharyngeal level, at which there is comparable expression in the thyroid primordiu
undisturbed in E10.5 Shh null embryos (arrowheads in B, E). An Nkx2.1-negative domain is
E12.5 (K). (C, F, I, L) Caudal end of the respiratory foregut, where Shh null embryos have a w
Nkx2.1-negative. Note also the grossly abnormal, unbranched and fused lung buds (F,L). Th
developing embryos. Abbreviations as in Fig. 3 and: Ph, pharynx. Scale bar (in A): 100 μm ilikely that the dynamic ventral-dorsal shift in Shh signalling is re-
quired for the onset of tracheo-oesophageal separation.
Cell proliferation during normal tracheo-oesophageal separation
To investigate the cellular mechanisms of tracheo-oesophageal
separation, we examined cell proliferation in the early foregut. No
signiﬁcant difference in the percentage of cells staining positive (H3-
index) for the mitotic marker phosphohistone H3 was detected along
the dorso-ventral axis of the untreated CBA/Ca foregut. This argues
against a role for localised cell proliferation in normal tracheo-
oesophageal separation, and reinforces the conclusion that outgrowth
speciﬁcally of the ventral foregut component is unlikely to underlie
tracheal development in mice. At E11.5, the undivided foregut had
signiﬁcantly lower H3-indices than the divided foregut (Supplemen-
tary Fig. 3), in agreement with our ﬁnding (Fig. 2A) that growth of the
entire foregut is most rapid after separation is complete.
Programmed cell death (PCD) during normal tracheo-oesophageal
separation
To determine whether PCDmight play a role in foregut separation,
we used immunohistochemistry for activated caspase-3 to identify
apoptotic cells in transverse sections (Figs. 5 and 6). A templating
technique (Sharma et al., 2004) enabled individual apoptotic cells
from equivalent levels of replicate embryos to be marked on a single
template section. This helped in discerning spatial PCD patterns,
despite the small overall number of caspase-3 positive cells. In
contrast to mitotic activity, considerable variation in PCD activity was
detected along both the rostro-caudal and dorso-ventral axes of the
foregut.
At E10.5, three sites of particularly intense epithelial PCD were
distinguished in normal embryos: in the laryngotracheal groove at theistochemistry in pooled wild type and heterozygous (A–C) and Shh null (D–L) embryos.
m. (B, E, H, K) Intermediate foregut level at which the dorso-ventral Nkx2.1 boundary is
still present in the Shh null at E11.5 (arrowheads and arrow in H) but is not evident at
ell-deﬁned ﬁstula that is either wholly (arrowheads in F, L) or partly (arrowhead in I)
is contrasts with the clearly separate trachea and oesophagus (arrow in C) of normally
n A, B, C, D, G; 50 μm in E, J; 67 μm in F, I, L; 33 μm in H, K.
Fig. 5. PCD in the E10.5 foregut: effect of Adriamycin and loss of Shh function. (A–H) Immunohistochemistry for activated caspase 3 on saline-treated (A–C; n=6), Adriamycin-
treated (D–F; n=6) and Shh null (G,H; n=3) embryos at E10.5. Transverse sections are from levels indicated on the schematic representations. Arrowheads indicate caspase 3-
positive (brown stained) apoptotic cells. (A1–F1) Templates used to illustrate spatial PCD patterns. Dots of different colour represent individual apoptotic cells from different
embryos and aremarked at their equivalent positions on the template. Note the lack of caspase 3-positive cells in the lateral walls of the Adriamycin-treated foregut (E, E1) compared
with the saline control (B, B1). There is a paucity of PCD in the Shh null foregut (H), despite the clear occurrence of dying cells in the dorsal neural tube of this embryo (inset in G).
Abbreviations as in Fig. 2, and: St, stomach. Scale bar (in A): 100 μm for all parts.
357A.S. Ioannides et al. / Developmental Biology 337 (2010) 351–362rostral end of the foregut (Figs. 5A, A1), at the dorso-ventral boundary
of the undivided foregut walls, more caudally (Figs. 5B, B1), and at the
sites of budding of the broncho-pulmonary primordia, most caudally
(Figs. 5C, C1). At E11.5, a similar concentration of PCD was observed
in the laryngotracheal groove (Figs. 6A, A1) and broncho-pulmonary
buds (Fig. 6G,G1). Notably, at intermediate rostro-caudal levels there
was a marked ventral-to-dorsal shift of PCD, both in the undivided
(Figs. 6B–E, B1–E1) and divided (Figs. 6F, F1) foregut. At the point of
tracheo-oesophageal separation, we detected a marked increase in
the number of dying cells at the point of separation (Figs. 6E, E1
arrows), a pattern that wasmaintained for a few sections caudal to the
level of separation (Figs. 6F, F1).
We quantiﬁed PCD by determining the proportion of caspase-3-
positive cells (PCD index) in dorso-ventral zones of the foregut. A
striking concentration of PCD was observed in the ventral laryngo-
tracheal groove at rostro-caudal level 1 (L1), with up to 25% of cells
dying (Fig. 7A). In contrast, ventral regions of the foregut more
caudally (L3,4,5) showed signiﬁcantly less PCD (pb0.004). In the
dorsal half of the foregut, L1 and L2 had a low PCD index, whereaslevels caudal to L2 exhibited markedly more apoptosis, with a peak
at L5–6, where as many as 25–30% of dorsal epithelial cells are dying
(Fig. 7A). Since L5 is the level at which tracheo-oesophageal sepa-
ration is actively occurring, we sub-divided the dorsal zone into
dorsal-most and middle zones, to determine whether PCD is
particularly associated with foregut wall invagination (middle
zone). While PCD is low in the middle zone rostrally, at L2 and L3
(Figs. 6B1, C1), PCD index rises sharply at L4 (Fig. 6D1) and peaks at
L5 (Fig. 6E1), where up to 32% of cells are dying (Fig. 7B). The
dorsal-most segment also has high levels of PCD, but this is also
present at L3, more rostrally. Hence, the two main characteristics of
PCD in the normal E11.5 foregut are a ventral-dorsal shift, and a
concentration of dying cells at the point of tracheo-oesophageal
separation.
PCD in models of abnormal tracheo-oesophageal development
The PCD pattern in Adriamycin-treated embryos is similar at both
E10.5 and E11.5. Dying cells localise to the laryngotracheal groove
Fig. 6. PCD during tracheo-oesophageal separation at E11.5 and E12.5: effect of Adriamycin and loss of Nkx2.1 or Apaf1 function. (A–W) Immunohistochemistry for activated caspase
3 on transverse sections through the foregut of E11.5 saline-treated (A–G; n=6), Adriamycin-treated (H–N; n=6) and Nkx2.1−/− (O–U; n=3) embryos, and of E12.5 Apaf1+/+
and Apaf1−/− embryos (V,W; n=3). Sections are from levels indicated on the schematic representation. (A1–N1) Templates used to illustrate spatial PCD patterns as described in
Fig. 5. Horizontal lines deﬁne foregut zones for calculation of PCD index (see Fig. 7). Arrows in (E, E1) indicate the concentration of apoptotic cells in epithelial ridges immediately
cranial to the point of foregut separation, a ﬁnding that is not seen in either Adriamycin-treated (L, L1) or Nkx2.1−/− (R–T) embryos. Arrowheads in (M1,N) show apoptotic cells in
the dorsal mesenchyme associated with a cellular condensation. Arrowheads in (O–U) highlight excessive apoptosis in Nkx2.1−/− embryo. Circles in (V,W) highlight the separated
trachea and oesophagus in Apaf1+/+ and Apaf1−/− embryos. Abbreviations as in Figs. 3, 4 and 5. Scale bar (in A): 50 μm for all parts.
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Fig. 7. Quantiﬁcation of PCD in the E11.5 foregut. Box plots showing PCD indices from
E11.5 saline-treated CBA/Ca mice at different rostro-caudal levels. Dorso-ventral zones
are deﬁned as in Fig. 6. Arrows indicate level at which foregut separation has occurred
at this stage. (A) PCD data for dorso-ventral zones with additional data (brown and pink
boxes) for the middle and lateral tracheal segments to illustrate budding of the bronchi.
(B) PCD data for dorsal-most and middle segments at levels 2 to 5. Note ventral-to-
dorsal switch in predominance of PCD as separation proceeds from caudal to rostral
within the foregut (compare black and grey bars in A). The point of foregut separation
coincides with a peak of PCD (A), with middle dorso-ventral zone showing greatest
intensity of apoptosis (B).
359A.S. Ioannides et al. / Developmental Biology 337 (2010) 351–362(Figs. 5D, D1 and 6H, H1), and to the origin of the broncho-pulmonary
buds (Figs. 5F, F1), as in saline control embryos. In contrast, the dorso-
ventral pattern of PCD localisation in the Adriamycin-treated foregut
is disrupted at intermediate rostro-caudal levels, both prior to the
onset of tracheo-oesophageal separation at E10.5, and while separa-
tion is ongoing at E11.5. Only one out of six Adriamycin-treated
embryos at E10.5 exhibited PCD clusters around the dorso-ventral
boundary, as seen in control embryos, with the remaining embryos
showing apoptotic cells at apparently random points along the
foregut dorso-ventral axis (Figs. 5E, E1).
Similar variability in dorso-ventral PCD location was seen in E11.5
Adriamycin-treated embryos with failed foregut separation (Figs. 6I–M
and I1–M1). Indeed, there is a striking lack of PCD in the middle foregut
zone (Figs. 6K, K1, L, L1), whereas PCD clusters are more frequently seen
in the dorsal-most foregut zone. Apoptotic cells also occur in the
mesenchyme dorsal to the undivided foregut, in association with an
apparent mesenchymal condensation at this site (Figs. 6M1, N, N1
arrowheads), whereas signiﬁcant PCD was not observed elsewhere in
the mesenchyme around the foregut.
Shh null embryos at E10.5, when wild type and heterozygous
littermates are already undergoing tracheo-oesophageal separation,
resemble Adriamycin-treated embryos in lacking PCD localisation at
the dorso-ventral boundary of the foregut. Occasional apoptotic cellsoccur apparently randomly along the dorso-ventral foregut axis.
Furthermore, the overall intensity of foregut PCD appears markedly
reduced in Shhmutants, compared to normally developing littermates
(Figs. 5G, H), a striking ﬁnding in view of the excessive apoptosis seen,
for example, in the neural tube of Shh−/− embryos (Fig. 5G inset).
We also examined PCD in another model of OA/TOF: embryos null
for Nkx2.1 exhibit failure of tracheo-oesophageal separation (Minoo
et al., 1999; Yuan et al., 2000). Wild type litter mates at E11.5 exhibit a
pattern and intensity of apoptosis closely resembling CBA/Ca embryos
(data not shown). In contrast, we found excessive PCD in the foregut
of Nkx2.1−/− embryos (Figs. 6O–U). Large numbers of caspase 3-
positive cells were observed at all rostro-caudal levels, with no
apparent dorso-ventral localisation. So plentiful was this PCD that it
could be readily visualised without use of the templating technique.
In conclusion, we have identiﬁed a disturbed pattern of foregut
PCD in three different models of OA/TOF. In particular, the con-
centration of dying cells at the point of tracheo-oesophageal
separation is lost in all three cases. There is great variation, however,
in the intensity of apoptosis: Adriamycin-treated embryos have
relatively normal numbers of dying cells, Shh−/− embryos show
reduced foregut apoptosis, and Nkx2.1−/− embryos exhibit excessive
apoptosis. These ﬁndings could indicate a potentially important role
for the spatial regulation of PCD during the process of tracheo-
oesophageal separation. However, we cannot rule out the alternative
view, that PCD could be a secondary consequence of the ongoing
morphogenesis.
Normal foregut morphogenesis in Apaf1 mutant embryos lacking PCD
To determine the requirement for PCD in tracheo-oesophageal
separation, we took a genetic approach by examining embryos null
for Apaf1, the homologue of CED-4/ARK which is required for
activation of caspase-9. The lack of Apaf-1 results in reduced
activation of caspase-3 and dramatically reduced PCD (Cecconi et
al., 1998). Hence, if PCD plays a functional role in tracheo-
oesophageal separation, we would expect to ﬁnd abnormalities in
the septation process in Apaf-1−/− embryos. At E11.5, the
morphology of foregut separation did not appear different between
−/− embryos and their wild type litter mates (data not shown).
Moreover, at E12.5, we observed a completely separated oesopha-
gus and trachea in all Apaf1 mutant and wild type embryos
examined, despite an apparent complete suppression of apoptosis
(Figs. 6V, W). Hence, it appears that the genetically determined lack
of apoptosis, which leads to defects in several other developmental
systems in Apaf1−/− embryos (Cecconi et al., 1998, 2004), does not
disrupt tracheo-oesophageal separation. We conclude that PCD is
not essential for foregut separation, despite its close spatio-temporal
correlation with this morphogenetic process.
Discussion
In the present study, we compared normal development of the
trachea and oesophagus with abnormal development in three mouse
models (Adriamycin, Shh and Nkx2.1) that exhibit malformations
resembling human OA/TOF. Despite the difference in causation of
these models, the morphological and molecular features of abnormal
early foregut development are remarkably similar. This raises the
possibility that human OA/TOF malformations may also originate
from a developmental pathogenesis like that seen in the mouse
models.
Does the respiratory foregut arise by septation or tracheal outgrowth?
Previous studies in both normal embryos and in the Adriamycin
rat model have generated contrasting theories to explain the origin
of a separate tracheal structure from the common foregut, and failure
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growth of the respiratory primordium as primarily responsible for
emergence of the trachea as a separate structure. According to this
idea, failure of tracheal growth is likely to be the primary cause of
OA/TOF (Sasaki et al., 2001; Zaw-Tun, 1982). In contrast, the
‘septation’ model views the formation of a septum across the foregut
tube as the critical event in tracheo-oesophageal separation, with
defective caudal–rostral propagation of septum formation being the
primary defect leading to OA/TOF. In the present study, we
measured the length of the respiratory foregut, and of its divided
and undivided components, prior to, during and following formation
of the trachea as a distinct embryonic structure. The analysis clearly
demonstrates that while total respiratory foregut length increases
linearly, this is independent of tracheo-oesophageal separation, with
similar dynamics in affected Adriamycin-treated embryos as in
untreated controls. Moreover, as the length of divided foregut
increases in normal embryos, so the absolute length of undivided
foregut decreases, a ﬁnding that is not predicted by the tracheal
outgrowth model. Finally, in an analysis of cellular proliferation, we
did not detect an enhanced rate of growth in the ventral foregut at
the time of origin of the trachea, as demanded by the tracheal
outgrowth hypothesis. Therefore, while rapid overall growth of the
foregut is an integral part of tracheo-oesophageal morphogenesis,
our ﬁndings are more consistent with the ‘septation’ theory of
tracheal development than with a model that invokes speciﬁc
outgrowth of the trachea.
In support of this conclusion are reports that bilateral epithelial
ridges, or invaginations, can be observed approaching each other in
the midline just rostral to (i.e. preceding) the point of tracheo-
oesophageal separation (Qi and Beasley, 2000; Williams et al., 2003).
We also observed bilateral epithelial ridges undergoing fusion leading
to separation of the tracheal and oesophageal tubes. These structures
were absent or morphologically abnormal in affected Adriamycin-
treated embryos, and in Shh−/− and Nkx2.1−/− mutant embryos.
Hence, lack of formation of lateral epithelial ridges correlates with
failed separation of the trachea and oesophagus in several systems,
making it seem likely that fusion of the lateral epithelial ridges leads
to septation of the normal foregut tube. Future studies using high-
resolution, real time imaging of the separating foregut should provide
further information on this point.
Is defective foregut separation associated with disturbance of
dorso-ventral gene expression patterning?
We next examined an unresolved issue relating to the role of
disturbed dorso-ventral gene expression patterning in failed tracheo-
oesophageal separation. Faulty separation occurs in mice lacking
either the dorsal foregut marker, Sox2, or the ventral foregut marker,
Nkx2.1 (Minoo et al., 1999; Que et al., 2007). Moreover, Sox2 is
ectopically expressed in the ventral foregut of Nkx2.1 mutants and,
conversely, Nkx2.1 is ectopically expressed in the dorsal foregut of
Sox2 mutants. These ﬁndings have led to the idea that disturbed
foregut dorso-ventral patterning may be a primary mechanism
leading to failure of tracheo-oesophageal separation (Minoo et al.,
1999; Que et al., 2007). We examined this question in the
Adriamycin mouse model of OA/TOF and found that failure of
foregut septation is not associated with a generalised loss of dorso-
ventral gene expression patterning in the foregut. Both Nkx2.1 and
Sox2 show appropriate patterning as Adriamycin-induced OA/TOF
develops. Nkx2.1 is also correctly patterned in the undivided Shh-
null foregut. On the other hand, the dynamic ventral-to-dorsal shift
in expression of Shh, which occurs just ahead of the caudal–rostral
wave of foregut separation, is abolished in Adriamycin-induced
foregut defects (Ioannides et al., 2003). This is consistent with
previous ﬁndings of a reduced level of Shh mRNA and protein in the
rat Adriamycin-treated foregut (Arsic et al., 2003; Arsic et al., 2004),and with failure of downregulation of Shh at the site of tracheo-
oesophageal separation (Orford et al., 2001). Moreover, reduced
levels of Gli2, a key member of the Shh signalling cascade, have been
found in the mesenchyme of the ﬁstula in Adriamycin-treated rats
(Spilde et al., 2003b), and in human neonates with OA/TOF (Spilde
et al., 2003a). Hence, from our analysis it appears that the spatio-
temporal shift in Shh expression is critical for normal tracheo-
oesophageal separation.
We found that the ﬁstula arising from the dorsal part of the
undivided, Adriamycin-treated foregut is Nkx2.1-negative at E11.5. In
contrast, the ﬁstula of the Adriamycin rat is reported to be Nkx2.1-
positive at E13.5 (Crisera et al., 1999) while the ﬁstula in the Shh null
mouse was found to have tracheal characteristics at E17.5 (Litingtung
et al., 1998). It seems likely that progressive ‘trachealisation’ of the
undivided foregut, as described in the Adriamycin rat model (Kluth et
al., 1987;Merei et al., 1998; Possögel et al., 1998), may account for this
difference in ﬁndings. Hence, there appears to be a gradual extension
of Nkx2.1 expression into the ﬁstula as a secondary, adaptive event,
converting the initially Nkx2.1-negative trifurcation branch at E11.5
into an Nkx2.1-positive ﬁstula from E13.5 onwards. Nevertheless, the
absence of tracheal cartilage from the oesophagotrachea of Adriamy-
cin-treated fetuses suggests that this process of trachealisation may
not progress to completion.
Localised cell proliferation and apoptosis—a role in tracheo-oesophageal
septation?
A third aim of the present study was to ask whether localised cell
proliferation may be involved in formation of the bilateral epithelial
ridges, or whether apoptosis may play a functional role in the fusion
and remodelling of the epithelial ridges as the trachea and
oesophagus separate. While we detected active cell proliferation in
the epithelium and underlying mesenchyme, there was no evidence
of proliferation ‘hot spots’ in the dorso-ventral foregut axis, that might
be causally related to epithelial ridge formation. Hence, localised cell
proliferation does not appear to be a signiﬁcant factor in foregut
separation.
In our analysis of apoptosis, dying cells were found to comprise up
to 30% of the lateral epithelial ridges, just prior to formation of the
septum and for a short period following tracheo-oesophageal
separation. This association of apoptosis with the lateral epithelial
ridges was disrupted in each of the three models of defective foregut
separation.Whereas Adriamycin-treated embryos showed a relatively
normal overall intensity of PCD, Shh−/− and Nkx2.1−/− embryos
exhibited diminished and excessive apoptosis respectively. Previous
studies have reported reduced apoptosis in the region of defective
tracheo-oesophageal separation in the Adriamycin rat model (Orford
et al., 2001; Qi and Beasley, 2000; Williams et al., 2000; Zhou et al.,
1999). Hence, considerable evidence exists to link PCD spatio-
temporally with morphogenetic foregut division.
To investigate whether apoptosis is functionally involved in
foregut separation, we studied the Apaf1 null mouse in which PCD
is reduced to extremely low levels (Cecconi et al., 1998). Strikingly,
despite an apparent complete suppression of apoptosis in Apaf−/−
embryos, we found that tracheo-oesophageal separation proceeds
to completion, with the formation of a normally separated
oesophagus and trachea. We conclude that apoptosis, although
plentiful in the vicinity of the foregut epithelial ridges, is not
functionally required for separation. This ﬁnding provides a strong
parallel with our recent analysis of apoptosis in mouse neural tube
closure (Massa et al., 2009) and with work on palatal shelf closure
(Takahara et al., 2004). In both of these studies, apoptosis was
shown to be spatio-temporally correlated with the closure event,
whereas experimental analysis failed to identify an essential role
for PCD in completion of morphogenesis. In contrast, other studies
have identiﬁed an apparent functional role for apoptosis in chick
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et al., 2002), indicating that this remains a research area of some
controversy.
Foregut epithelial remodelling and the origin of apoptotic cells
Disruption of the epithelial layer covering the fusing bilateral
foregut ridges, and epithelial reformation to create separate tracheal
and oesophageal tubes, are essential events for tracheo-oesophageal
septation. Similar epithelial remodelling processes occur in other
morphogenetic fusion events, including neurulation and palatal clo-
sure, each with its closely associated apoptosis. If cell death is not
required for epithelial remodelling, as is suggested by our data, then it
seems most likely that apoptosis is a secondary consequence of the
morphogenesis. Indeed, it is well know that cells which lose adhesive
contacts with their neighbours, or with the underlying extracellular
matrix, are prone to undergoing apoptosis, a process termed ‘anoikis’
(Gilmore, 2005). In the neural folds, the Nf2 tumour suppressor (also
called Merlin) regulates the assembly and maintenance of apico-
lateral junctional complexes and is required for the avoidance of
anoikis (McLaughlin et al., 2007). It seems possible, therefore, that
fusion of the lateral epithelial ridges and the associated epithelial
remodelling results in a proportion of cells transiently losing their
cell–cell or cell–matrix contacts. These cells undergo anoikis,
producing the apoptosis that is associated with normal tracheo-oeso-
phageal separation.
Alternative mechanisms of epithelial ridge formation and fusion
Since neither localised cell proliferation nor apoptosis appear
implicated in the mechanism of foregut separation, it is important to
consider alternative cellular processes that can lead to deformation of
epithelial sheets during morphogenesis. For example, contraction of
apically located actin microﬁlaments is essential for the elevation and
bending of the rostral neural folds (Morriss-Kay and Tuckett, 1985;
Sadler et al., 1986; Ybot-Gonzalez and Copp, 1999), and constrains the
direction of expansion of the pharyngeal pouches (Quinlan et al.,
2004). However, the epithelial foregut ridges comprise convex bulges
into the lumen and, to achieve this epithelial deformation, contracting
microﬁlaments would need to be localised basally, rather than
apically as in other systems. Another mechanism that might be
implicated in epithelial ridge formation is localised expansion of the
mesenchyme underlying the lateral foregut epithelium, as observed in
the mouse cranial neural folds which accumulate a hyaluronan-rich
extracellular matrix (Morris-Wiman and Brinkley, 1990; Solursh and
Morriss, 1977). However, in the present study, we did not observe
obvious alterations in intercellular space within the mesenchyme of
the lateral epithelial ridges. Clearly, there is considerable scope for
further studies of the cellular basis of foregut separation in
mammalian embryos.
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